Technology Embedded in the Workflow
Our offerings improve the entire research process. Utilizing our unique integrated electronic health record (EHR) approach, we apply ObjectiveHealth technology and health algorithms to find the right patients for the right specific trials. This differentiating process leads to accelerated study timelines. Let our advantages become your advantage.
Tech That Works for Science
Our software and processes, coupled with our relationships with providers, enable us to deliver a unique service that will accelerate your traditional trial execution while having the flexibility to support hybrid and virtual trial designs.
Our experience, tools, and processes offer a smarter, more efficient way to find at-risk patients and deliver qualified research candidates:
Using technology-enabled data access for faster trial screening and enrollment.
Looping together physicians, investigators, coordinators, and patients seamlessly.
Through precise clinical insights provided for physicians, patients, and research teams at the point of care.
We apply our proprietary ObjectiveHealth technology and health algorithms to find the right patients for the right trials by utilizing our unique integrated EHR approach to optimize trial outcomes and better support the ongoing participation of trial participants.
Identify and prequalify patients for trials.
We have the ability to prescreen patients by using actual EHR to find the ideal patients for trials. This leads to more accurate patient identification for each succeeding trial.
Our dashboard uses custom metrics and real-time data, allowing for more efficient and accurate patient data tracking in the context of research. This, combined with enhancements like wearables and electronic patient reporting options, allows for a more complete picture of our study patients.
Those patients who are at risk and not eligible for current trials will be supported by our platform. What’s more, our system continuously reevaluates each of these patients to determine if a new available trial might be an option.
Our direct access to patients in both a real-world setting and a clinical trial setting has created several opportunities to advance medical research.
- Differences in liver elastography in non-diabetic, prediabetic, and known diabetic patients based on HbA1c levels in community-based gastroenterology practices (AJG 2020). Learn more.
- Understanding gender differences in NAFLD progression utilizing common liver biomarkers (AJG 2020). Learn more.
- Effectiveness of non-invasive test sequencing for screening patients with moderate to advanced NASH fibrosis (TBA).
- Improving patient retention in NASH trials with a technology-enabled research team in the GI practice (ACG 2021).